openPR Logo
Press release

Flu Vaccine Market Trends | Quadrivalent & mRNA-Based Vaccines Gain Momentum | Major Companies - AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc

06-16-2025 09:42 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Flu Vaccine Market

Flu Vaccine Market

The global flu vaccine market reached US$ 5.70 billion in 2024 and is expected to reach US$ 10.74 billion by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033.

Flu Vaccine Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/flu-vaccine-market?ca

The flu vaccine is an annual immunization designed to protect against the most common strains of the influenza virus expected each season. Available in injectable and nasal spray forms, it helps reduce the risk of flu-related illness, hospitalization, and complications, especially in vulnerable populations like the elderly, young children, and those with chronic conditions. Widespread vaccination also contributes to community immunity, limiting the spread of the virus.

Major players in the Flu Vaccine market

The prominent players in Flu Vaccine market research report are: AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc., Hualan Biological Engineering Inc., Sinovac Biotech Ltd., GSK Plc, Pfizer Inc., and CureVac N.V.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Flu Vaccine Market Dynamics

Increasing product innovations are driving the growth of the flu vaccine market. New advancements like adjuvanted and needle-free nasal vaccines offer broader and longer-lasting protection. For instance, Mylab and SII launched Nasovac S4 in October 2023, India's first nasal flu vaccine, while Cadila introduced the Cadiflu Tetra Vaccine. Such innovations are boosting demand for effective immunization options.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/flu-vaccine-market?ca

Flu Vaccine Market Segments

By Type: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines

By Application: Children < 3 Years, Adults and Children > 3 years

The Flu Vaccine industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Flu Vaccine Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu Vaccine Market Trends | Quadrivalent & mRNA-Based Vaccines Gain Momentum | Major Companies - AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc here

News-ID: 4067710 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

United States DHA Industry Sector 2025: Vita Foods Asia 2025 | Leading Companies - Solutex GC SL, Shandong Yuwang Pharmaceutical Co.,Ltd, Nordic Naturals, Omega Protein Corporation, Copeinica
United States DHA Industry Sector 2025: Vita Foods Asia 2025 | Leading Companies …
DataM Intelligence has published a new research report on "DHA Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Adding DHA to infant formula enhances visual acuity in
United States Cosmeceuticals Industry Sector 2025: Vita Foods Asia Summit 2025 | Ambe Phytoextracts, L'Oréal S.A., Osmosis Skincare, Dermalogica, SkinSciPac, LLC
United States Cosmeceuticals Industry Sector 2025: Vita Foods Asia Summit 2025 | …
DataM Intelligence has published a new research report on "cosmeceuticals Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Europe leads the global cosmeceuticals market, driven by strong
United States Cosmetic Ingredients Industry Sector 2025: Vita Foods Asia 2025 | Leading Companies are Ambe Phytoextracts, Evonik Industries AG, Clariant AG, Dow Chemical Company, Symrise AG, Ashland Global Holdings Inc.
United States Cosmetic Ingredients Industry Sector 2025: Vita Foods Asia 2025 | …
DataM Intelligence has published a new research report on "Cosmetic Ingredients Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Also in April 2025, BASF unveiled natural-based innovations
Gelatine in Europe Industry Sector Growth 2025-2032 | Size $519.24M, Vita Foods Asia 2025: Halavet Gida San Ve Tic A.S, Darling Ingredients, Inc, Ewald-Gelatine GmbH, Italgel S.p.A and Jellice Pioneer Europe B.V.
Gelatine in Europe Industry Sector Growth 2025-2032 | Size $519.24M, Vita Foods …
DataM Intelligence has published a new research report on "Europe Gelatine Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. European regulations ensure raw material safety and traceability,

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion